Table 5.
Group | IL-10 (ng/L) | IL-4 (ng/L) | ||
---|---|---|---|---|
|
|
|||
Before treatment | After treatment | Before treatment | After treatment | |
Study Group B (n=40) | 10.45±2.56 | 14.26±2.33 | 14.73±2.14 | 5.78±1.66 |
Study Group A (n=40) | 10.34±2.74 | 18.35±2.67 | 14.06±2.21 | 9.98±1.93 |
Control group (n=40) | 3.26±0.86a,b | 4.97±1.37a,b | ||
T/F | 136.973 | 7.074 | 333.267 | 10.410 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Note: IL-10: Interleukin-10, IL-4: Interleukin-4.
P < 0.05, compare with group B;
P < 0.05, compare with group A.